Overview

Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD

Status:
Completed
Trial end date:
2017-08-03
Target enrollment:
Participant gender:
Summary
The overall goal of this research is to use neurophysiological measures to profile strengths and deficits for Attention Deficit Hyperactivity Disorder co-morbidity in Autism Spectrum Disorder to clarify diagnosis and to predict treatment response.
Phase:
Early Phase 1
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Treatments:
Methylphenidate